T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
2076
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $511K | ﹤0.01% |
8,753
+3,806
| +77% | +$240K |
|
2077
Comtech Telecommunications
CMTL
$52.7M
| $509K | ﹤0.01% |
23,023
| – | – |
|
|
KBAL
2078
DELISTED
Kimball International
KBAL
| $506K | ﹤0.01% |
27,090
| – | – |
|
2079
Silicon Laboratories
SLAB
$7.28B
| $504K | ﹤0.01% |
5,708
+1,490
| +35% | +$134K |
|
|
ARNA
2080
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $502K | ﹤0.01% |
14,777
+20
| +0.1% | +$570 |
|
|
CAMP
2081
DELISTED
CalAmp Corp.
CAMP
| $501K | ﹤0.01% |
1,017
-540
| -35% | -$279K |
|
|
LMNX
2082
DELISTED
Luminex Corp
LMNX
| $499K | ﹤0.01% |
25,310
| – | – |
|
2083
BOK Financial
BOKF
$8.85B
| $495K | ﹤0.01% |
5,360
+676
| +14% | +$59.6K |
|
2084
iShares Core S&P 500 ETF
IVV
$910B
| $494K | ﹤0.01% |
1,838
-1,366
| -43% | -$358K |
|
2085
Sony
SONY
$138B
| $494K | ﹤0.01% |
55,000
| – | – |
|
|
B
2086
Barrick Mining
B
$67.3B
| $493K | ﹤0.01% |
33,955
-115
| -0.3% | -$1.7K |
|
|
REGI
2087
DELISTED
Renewable Energy Group, Inc.
REGI
| $493K | ﹤0.01% |
41,795
+13,600
| +48% | +$157K |
|
2088
Hackett Group
HCKT
$277M
| $492K | ﹤0.01% |
31,290
| – | – |
|
|
POT
2089
DELISTED
Potash Corp Of Saskatchewan
POT
| $492K | ﹤0.01% |
23,900
+200
| +0.8% | +$3.88K |
|
2090
Center Bancorp
CNOB
$1.81B
| $491K | ﹤0.01% |
19,056
-3,410
| -15% | -$89.5K |
|
|
FFKT
2091
DELISTED
Farmers Capital Bank Corp
FFKT
| $489K | ﹤0.01% |
12,708
+1,000
| +9% | +$41.4K |
|
|
GCI
2092
DELISTED
Gannett Co., Inc
GCI
| $489K | ﹤0.01% |
42,200
-18,274
| -30% | -$191K |
|
2093
Stewart Information Services
STC
$2.07B
| $488K | ﹤0.01% |
11,529
-10
| -0.1% | -$395 |
|
2094
Valley National Bancorp
VLY
$8.3B
| $486K | ﹤0.01% |
43,358
-100
| -0.2% | -$1.16K |
|
2095
Lands' End
LE
$390M
| $485K | ﹤0.01% |
24,821
+10,900
| +78% | +$151K |
|
|
ENDP
2096
DELISTED
Endo International plc
ENDP
| $485K | ﹤0.01% |
62,520
-19,630
| -24% | -$147K |
|
2097
Sterling Infrastructure
STRL
$16.9B
| $483K | ﹤0.01% |
29,673
-13,600
| -31% | -$224K |
|
2098
Corbus Pharmaceuticals
CRBP
$195M
| $482K | ﹤0.01% |
2,261
+1,677
| +287% | +$359K |
|
2099
Designer Brands
DBI
$312M
| $480K | ﹤0.01% |
22,434
-5,918
| -21% | -$122K |
|
|
WWE
2100
DELISTED
World Wrestling Entertainment
WWE
| $480K | ﹤0.01% |
15,698
-10
| -0.1% | -$270 |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.